Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Birchcliff Energy stock logo

1. Birchcliff Energy OTCMKTS:BIREF

$4.12 -0.12 (-2.78%)
As of 03:54 PM Eastern

Birchcliff Energy Ltd., an intermediate oil and natural gas company, explores for, develops, and produces natural gas, light oil, condensate, and other natural gas liquids in Western Canada. More about Birchcliff Energy

Market Capitalization
$1.13 billion
P/E Ratio
21.69
Consensus Rating
Strong Buy
Volume
17,037 shares
Average Volume
77,022 shares
Today's Range
$4.12
$4.22
Senseonics stock logo

2. Senseonics NYSE:SENS

$0.44 -0.01 (-1.51%)
Closing price 04:00 PM Eastern
Extended Trading
$0.44 +0.00 (+0.73%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about Senseonics

Market Capitalization
$355.04 million
P/E Ratio
-3.35
Consensus Rating
Buy
Consensus Price Target
$1.54 (+252.8% Upside)
Volume
3.98 million shares
Average Volume
7.83 million shares
Ultrapar Participacoes stock logo

3. Ultrapar Participacoes NYSE:UGP

$4.11 +0.03 (+0.61%)
Closing price 03:59 PM Eastern
Extended Trading
$4.11 +0.00 (+0.12%)
As of 07:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ultrapar Participações SA, through its subsidiaries, operates in the energy and infrastructure business in Brazil. The company distributes liquefied petroleum gas to residential, commercial, and industrial consumers, in addition to renewable electricity and compressed natural gas. More about Ultrapar Participacoes

Market Capitalization
$4.58 billion
P/E Ratio
9.12
Consensus Rating
Buy
Consensus Price Target
$4.50 (+9.6% Upside)
Volume
6.15 million shares
Average Volume
1.86 million shares
Foghorn Therapeutics stock logo

4. Foghorn Therapeutics NASDAQ:FHTX

$4.89 -0.12 (-2.40%)
Closing price 04:00 PM Eastern
Extended Trading
$4.91 +0.02 (+0.41%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Foghorn Therapeutics Inc, a clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States. More about Foghorn Therapeutics

Market Capitalization
$276.43 million
P/E Ratio
-4.11
Consensus Rating
Buy
Consensus Price Target
$11.00 (+124.9% Upside)
Volume
155,464 shares
Average Volume
125,413 shares
TuHURA Biosciences stock logo

5. TuHURA Biosciences NASDAQ:HURA

$2.48 +0.01 (+0.40%)
Closing price 04:00 PM Eastern
Extended Trading
$2.42 -0.06 (-2.22%)
As of 07:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$124.12 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+410.8% Upside)
Volume
106,967 shares
Average Volume
296,194 shares
Today's Range
$2.44
$2.52
Climb Bio stock logo

6. Climb Bio NASDAQ:CLYM

$2.01 +0.02 (+1.01%)
As of 04:00 PM Eastern

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb Bio

Market Capitalization
$136.20 million
P/E Ratio
-2.87
Consensus Rating
Buy
Consensus Price Target
$9.25 (+360.2% Upside)
Volume
386,120 shares
Average Volume
365,292 shares
TriSalus Life Sciences stock logo

7. TriSalus Life Sciences NASDAQ:TLSI

$4.65 -0.02 (-0.43%)
Closing price 04:00 PM Eastern
Extended Trading
$4.66 +0.00 (+0.11%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$231.88 million
P/E Ratio
-3.94
Consensus Rating
Buy
Consensus Price Target
$10.90 (+134.4% Upside)
Volume
60,432 shares
Average Volume
72,255 shares
Hochschild Mining stock logo

8. Hochschild Mining OTCMKTS:HCHDF

$4.80 0.00 (-0.08%)
As of 02:33 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$2.47 billion
Consensus Rating
Buy
Volume
11,597 shares
Average Volume
32,362 shares
Today's Range
$4.77
$4.91
50-Day Range
$3.60
$4.80
Skye Bioscience stock logo

9. Skye Bioscience NASDAQ:SKYE

$3.93 +0.05 (+1.29%)
Closing price 04:00 PM Eastern
Extended Trading
$3.98 +0.05 (+1.40%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Skye Bioscience, Inc, a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. More about Skye Bioscience

Market Capitalization
$121.78 million
P/E Ratio
-3.71
Consensus Rating
Buy
Consensus Price Target
$14.75 (+275.3% Upside)
Volume
290,284 shares
Average Volume
618,191 shares
Medicus Pharma stock logo

10. Medicus Pharma NASDAQ:MDCX

$2.32 -0.19 (-7.57%)
As of 04:00 PM Eastern

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. More about Medicus Pharma

Market Capitalization
$41.34 million
P/E Ratio
-1.73
Consensus Rating
Buy
Consensus Price Target
$23.50 (+912.9% Upside)
Volume
409,470 shares
Average Volume
252,208 shares
zSpace stock logo

11. zSpace NASDAQ:ZSPC

$0.98 -0.12 (-10.93%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$23.55 million
Consensus Rating
Buy
Consensus Price Target
$10.00 (+920.6% Upside)
Volume
2.52 million shares
Average Volume
232,745 shares
Today's Range
$0.87
$1.13
Plus Therapeutics stock logo

12. Plus Therapeutics NASDAQ:PSTV

$0.68 -0.15 (-17.74%)
Closing price 04:00 PM Eastern
Extended Trading
$0.69 +0.01 (+1.36%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus Therapeutics

Market Capitalization
$67.86 million
P/E Ratio
-0.31
Consensus Rating
Buy
Consensus Price Target
$7.88 (+1,051.8% Upside)
Volume
47.65 million shares
Average Volume
20.90 million shares
Mereo BioPharma Group stock logo

13. Mereo BioPharma Group NASDAQ:MREO

$2.06 +0.10 (+5.10%)
Closing price 04:00 PM Eastern
Extended Trading
$2.08 +0.02 (+0.83%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$327.54 million
P/E Ratio
-29.43
Consensus Rating
Buy
Consensus Price Target
$7.40 (+259.2% Upside)
Volume
1.88 million shares
Average Volume
1.64 million shares
Western Copper & Gold stock logo

14. Western Copper & Gold NYSE:WRN

$1.97 -0.01 (-0.51%)
As of 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$397.26 million
P/E Ratio
-98.50
Consensus Rating
Buy
Consensus Price Target
$4.25 (+115.7% Upside)
Volume
713,459 shares
Average Volume
410,135 shares
SAB Biotherapeutics stock logo

15. SAB Biotherapeutics NASDAQ:SABS

$2.01 +0.06 (+3.08%)
Closing price 04:00 PM Eastern
Extended Trading
$2.00 -0.01 (-0.75%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SAB Biotherapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. More about SAB Biotherapeutics

Market Capitalization
$20.93 million
P/E Ratio
-0.50
Consensus Rating
Buy
Consensus Price Target
$9.75 (+385.1% Upside)
Volume
106,328 shares
Average Volume
557,683 shares
ImmunityBio stock logo

16. ImmunityBio NASDAQ:IBRX

$2.46 -0.11 (-4.28%)
Closing price 04:00 PM Eastern
Extended Trading
$2.46 0.00 (-0.20%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.33 billion
P/E Ratio
-5.12
Consensus Rating
Buy
Consensus Price Target
$10.75 (+337.0% Upside)
Volume
8.08 million shares
Average Volume
8.15 million shares
Stardust Power stock logo

17. Stardust Power NASDAQ:SDST

$3.10 +0.02 (+0.65%)
Closing price 04:00 PM Eastern
Extended Trading
$3.12 +0.02 (+0.81%)
As of 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$26.22 million
P/E Ratio
-0.55
Consensus Rating
Buy
Consensus Price Target
$51.13 (+1,549.2% Upside)
Volume
209,238 shares
Average Volume
414,105 shares
FiscalNote stock logo

18. FiscalNote NYSE:NOTE

$4.61 -0.05 (-1.07%)
Closing price 03:59 PM Eastern
Extended Trading
$4.62 +0.01 (+0.22%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FiscalNote Holdings, Inc operates as technology company North America, Europe, Australia, and Asia. It combines artificial intelligence technology, machine learning, and other technologies with analytics, workflow tools, and expert research. More about FiscalNote

Market Capitalization
$66.13 million
P/E Ratio
-1.20
Consensus Rating
Buy
Consensus Price Target
$29.25 (+534.5% Upside)
Volume
140,239 shares
Average Volume
251,299 shares
Perspective Therapeutics stock logo

19. Perspective Therapeutics NYSE:CATX

$3.43 +0.08 (+2.39%)
Closing price 04:00 PM Eastern
Extended Trading
$3.42 -0.02 (-0.44%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$248.78 million
Consensus Rating
Buy
Consensus Price Target
$12.56 (+266.1% Upside)
Volume
750,348 shares
Average Volume
915,598 shares
Today's Range
$3.33
$3.50
Quince Therapeutics stock logo

20. Quince Therapeutics NASDAQ:QNCX

$1.63 +0.02 (+1.24%)
Closing price 04:00 PM Eastern
Extended Trading
$1.64 +0.01 (+0.86%)
As of 06:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$87.55 million
P/E Ratio
-1.50
Consensus Rating
Buy
Consensus Price Target
$8.14 (+399.6% Upside)
Volume
246,290 shares
Average Volume
227,754 shares
Protara Therapeutics stock logo

21. Protara Therapeutics NASDAQ:TARA

$4.35 -0.06 (-1.36%)
Closing price 04:00 PM Eastern
Extended Trading
$4.40 +0.05 (+1.15%)
As of 07:46 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Protara Therapeutics, Inc, a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. More about Protara Therapeutics

Market Capitalization
$167.82 million
P/E Ratio
-2.69
Consensus Rating
Buy
Consensus Price Target
$19.60 (+350.6% Upside)
Volume
604,052 shares
Average Volume
351,607 shares
PolyPid stock logo

22. PolyPid NASDAQ:PYPD

$3.34 +0.01 (+0.30%)
Closing price 04:00 PM Eastern
Extended Trading
$3.40 +0.06 (+1.77%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. More about PolyPid

Market Capitalization
$53.11 million
P/E Ratio
-0.87
Consensus Rating
Buy
Consensus Price Target
$12.40 (+271.3% Upside)
Volume
62,120 shares
Average Volume
190,779 shares
Ovid Therapeutics stock logo

23. Ovid Therapeutics NASDAQ:OVID

$1.30 -0.10 (-7.14%)
Closing price 04:00 PM Eastern
Extended Trading
$1.36 +0.05 (+4.23%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$92.44 million
P/E Ratio
-2.45
Consensus Rating
Buy
Consensus Price Target
$3.10 (+138.5% Upside)
Volume
3.01 million shares
Average Volume
1.12 million shares
Black Diamond Therapeutics stock logo

24. Black Diamond Therapeutics NASDAQ:BDTX

$3.79 +0.06 (+1.61%)
Closing price 04:00 PM Eastern
Extended Trading
$3.80 +0.02 (+0.40%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Black Diamond Therapeutics, Inc, a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. More about Black Diamond Therapeutics

Market Capitalization
$215.80 million
P/E Ratio
16.48
Consensus Rating
Buy
Consensus Price Target
$11.00 (+190.2% Upside)
Volume
1.01 million shares
Average Volume
1.82 million shares
CytomX Therapeutics stock logo

25. CytomX Therapeutics NASDAQ:CTMX

$3.19 -0.04 (-1.24%)
Closing price 04:00 PM Eastern
Extended Trading
$3.18 -0.01 (-0.31%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX Therapeutics

Market Capitalization
$526.06 million
P/E Ratio
5.70
Consensus Rating
Buy
Consensus Price Target
$5.42 (+69.8% Upside)
Volume
4.27 million shares
Average Volume
3.36 million shares